The Valley Desk

ArticleEuropean urology focusPublished

Enhancing the Immunogenicity of Nivolumab plus Ipilimumab with Live Bacterial Supplementation in Metastatic Renal Cell Carcinoma

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source

Publication record

Type
Article
Venue
European urology focus
Published
Subject terms
Humans; Clostridium butyricum; Carcinoma, Renal Cell; Kidney Neoplasms; Neoplasm Metastasis; Antineoplastic Combined Chemotherapy Protocols; Ipilimumab; Nivolumab; Immune Checkpoint Inhibitors
PubMed ID
39837716
Added to directory
Source checked

Report a correction or request removal